These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 21371907)

  • 1. Three Rs Approaches in the Production and Quality Control of Fish Vaccines.
    Midtlyng PJ; Hendriksen C; Balks E; Bruckner L; Elsken L; Evensen O; Fyrand K; Guy A; Halder M; Hawkins P; Kisen G; Romstad AB; Salonius K; Smith P; Sneddon LU
    Biologicals; 2011 Mar; 39(2):117-28. PubMed ID: 21371907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three Rs potential in the development and quality control of immunobiologicals.
    Halder M
    ALTEX; 2001; 18 Suppl 1():13-47. PubMed ID: 11854853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The consistency approach for quality control of vaccines - a strategy to improve quality control and implement 3Rs.
    De Mattia F; Chapsal JM; Descamps J; Halder M; Jarrett N; Kross I; Mortiaux F; Ponsar C; Redhead K; McKelvie J; Hendriksen C
    Biologicals; 2011 Jan; 39(1):59-65. PubMed ID: 21277791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The five Rs: refinement, reduction, replacement. A regulatory revolution.
    Lucken RN
    Dev Biol Stand; 1996; 86():67-72. PubMed ID: 8785993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Replacement, reduction or refinement of animal use in the quality control of veterinary vaccines: development, validation and implementation.
    van der Kamp MD
    Dev Biol Stand; 1996; 86():73-6. PubMed ID: 8785994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Global harmonization of vaccine testing requirements: Making elimination of the ATT and TABST a concrete global achievement.
    Viviani L; Halder M; Gruber M; Bruckner L; Cussler K; Sanyal G; Srinivas G; Goel S; Kaashoek M; Litthauer D; Lopes da Silva AL; Sakanyan E; Aprea P; Jin H; Vandeputte J; Seidle T; Yakunin D
    Biologicals; 2020 Jan; 63():101-105. PubMed ID: 31699501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alternatives to the use of animals in R & D and quality control of veterinary vaccines: an industry view.
    Verschueren C; Zänker S
    Dev Biol Stand; 1996; 86():49-51. PubMed ID: 8785991
    [No Abstract]   [Full Text] [Related]  

  • 8. The vaccines consistency approach project: an EPAA initiative.
    De Mattia F; Hendriksen C; Buchheit KH; Chapsal JM; Halder M; Lambrigts D; Redhead K; Rommel E; Scharton-Kersten T; Sesardic T; Viviani L; Ragan I
    Pharmeur Bio Sci Notes; 2015; 2015():30-56. PubMed ID: 26830158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Consistency as tool to support in vitro batch potency testing in GMP production.
    Stirling C
    Dev Biol (Basel); 2012; 134():115-8. PubMed ID: 22888603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulatory acceptance and use of 3R models: a multilevel perspective.
    Schiffelers MJ; Blaauboer BJ; Hendriksen CF; Bakker WE
    ALTEX; 2012; 29(3):287-300. PubMed ID: 22847256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Animal testing for vaccines. Implementing replacement, reduction and refinement: challenges and priorities.
    Akkermans A; Chapsal JM; Coccia EM; Depraetere H; Dierick JF; Duangkhae P; Goel S; Halder M; Hendriksen C; Levis R; Pinyosukhee K; Pullirsch D; Sanyal G; Shi L; Sitrin R; Smith D; Stickings P; Terao E; Uhlrich S; Viviani L; Webster J
    Biologicals; 2020 Nov; 68():92-107. PubMed ID: 33041187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvants and immunostimulants in fish vaccines: current knowledge and future perspectives.
    Tafalla C; Bøgwald J; Dalmo RA
    Fish Shellfish Immunol; 2013 Dec; 35(6):1740-50. PubMed ID: 23507338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent progress and future directions for reduction, refinement, and replacement of animal use in veterinary vaccine potency and safety testing: a report from the 2010 NICEATM-ICCVAM International Vaccine Workshop.
    Stokes WS; Kulpa-Eddy J; Brown K; Srinivas G; McFarland R
    Dev Biol (Basel); 2012; 134():9-21. PubMed ID: 22888590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potency testing of veterinary vaccines: the way from in vivo to in vitro.
    Romberg J; Lang S; Balks E; Kamphuis E; Duchow K; Loos D; Rau H; Motitschke A; Jungbäck C
    Biologicals; 2012 Jan; 40(1):100-6. PubMed ID: 22075457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reducing the use of the target animal batch safety test for veterinary vaccines.
    Roberts B; Lucken RN
    Dev Biol Stand; 1996; 86():97-102. PubMed ID: 8785997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Towards eliminating the use of animals for regulatory required vaccine quality control.
    Hendriksen CF
    ALTEX; 2006; 23(3):187-90. PubMed ID: 17086348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Good Cell Culture Practice. ECVAM Good Cell Culture Practice Task Force Report 1.
    Hartung T; Balls M; Bardouille C; Blanck O; Coecke S; Gstraunthaler G; Lewis D;
    Altern Lab Anim; 2002; 30(4):407-14. PubMed ID: 12234246
    [No Abstract]   [Full Text] [Related]  

  • 18. Fish vaccine antigens produced or delivered by recombinant DNA technologies.
    Leong JC; Anderson E; Bootland LM; Chiou PW; Johnson M; Kim C; Mourich D; Trobridge G
    Dev Biol Stand; 1997; 90():267-77. PubMed ID: 9270855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of use of animals in regulatory genotoxicity testing: Identification and implementation opportunities-Report from an ECVAM workshop.
    Pfuhler S; Kirkland D; Kasper P; Hayashi M; Vanparys P; Carmichael P; Dertinger S; Eastmond D; Elhajouji A; Krul C; Rothfuss A; Schoening G; Smith A; Speit G; Thomas C; van Benthem J; Corvi R
    Mutat Res; 2009; 680(1-2):31-42. PubMed ID: 19765670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody responses correlate with antigen dose and in vivo protection for oil-adjuvanted, experimental furunculosis (Aeromonas salmonicida subsp. salmonicida) vaccines in Atlantic salmon (Salmo salar L.) and can be used for batch potency testing of vaccines.
    Romstad AB; Reitan LJ; Midtlyng P; Gravningen K; Evensen Ø
    Vaccine; 2013 Jan; 31(5):791-6. PubMed ID: 23219439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.